Walleye Capital’s Insmed INSM Stock Holding History

Walleye Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$949K	Sell	8,900 -14,200	-61%	-$1.72M	﹤0.01%	2175
2026 Q1	$3.78M	Sell	23,100 -9,500	-29%	-$1.46M	0.02%	987
2025 Q4	$5.67M	Sell	32,600 -26,600	-45%	-$4.85M	0.02%	1055
2025 Q3	$8.53M	Buy	59,200 +48,100	+433%	+$5.89M	0.03%	620
2025 Q2	$1.12M	Buy	11,100 +7,600	+217%	+$581K	﹤0.01%	1964
2025 Q1	$267K	Sell	3,500 -65,300	-95%	-$5M	﹤0.01%	3035
2024 Q4	$4.75M	Buy	68,800 +25,200	+58%	+$1.81M	0.01%	1111
2024 Q3	$3.18M	Buy	+43,600	New	+$3.22M	0.01%	1532
2023 Q2	–	Sell	-20,600	Closed	-$351K	–	4568
2023 Q1	$351K	Buy	+20,600	New	+$400K	0.01%	1988
2019 Q3	–	Sell	-22,000	Closed	-$563K	–	2051
2019 Q2	$563K	Buy	+22,000	New	+$613K	0.06%	446

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Walleye Capital's INSM Position: Q2 2026 in Review

Walleye Capital reduced its Insmed (INSM) stake by 98% in Q2 2026, selling an estimated $8.53M and leaving 1,384 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #3684.

Walleye Capital first reported a position in INSM in Q4 2021 and has held it in 16 quarters since. The position peaked at $11.7M in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Walleye Capital held 1,384 shares of Insmed worth $148K as of Q2 2026.
Walleye Capital sold 70,435 Insmed shares in Q2 2026, an estimated $8.53M.
Insmed made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3684 holding.
Walleye Capital first reported a position in Insmed in Q4 2021 and has held it in 16 quarters since.
Walleye Capital's Insmed position peaked at $11.7M in Q1 2026.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.